Jean Jacques Bienaime - Insider Trading & Ownership

Location
925 Page Mill Road, Palo Alto, CA
Summary
The estimated net worth of Jean Jacques Bienaime is at least $57.3M dollars as of June 12, 2025. Jean Jacques Bienaime is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $55.6M. Jean Jacques Bienaime is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.27M. Jean Jacques Bienaime is the Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $342K. Jean Jacques Bienaime is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $78.7K.
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Jean Jacques Bienaime

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMRN BIOMARIN PHARMACEUTICAL INC Director $55.6M May 20, 2024
INCY INCYTE CORP Director $1.27M Jun 10, 2025
IMNM Immunome Inc. Director $342K +$165K +93.5% Jun 10, 2025
KROS Keros Therapeutics, Inc. Director $78.7K Jun 4, 2025

Insider Transactions Reported by Jean Jacques Bienaime:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.